. The graphic layout of the session Figure 2 . Professor JGF Cleland (Hull, UK) (right) and Dr P. Rubis (Krakow, PL) (left) welcome the audience and ask first presenter Professor P. Podolec (Krakow, PL) to the floor Milan, Italy. In the beginning, Professor Alfieri presented a highly complex candidate for the cardiac operation, who by the definition did not have a rare cardiovascular diseases, however, due to severe course of the disease and numerous commorbidites, any decision regarding an intervention was extremely difficult and required great expertise. Therefore, Professor Alfieri stressed that not necessarily patient has to have definition-fulfilled diagnosis of rare disease to be considered truly RARE. Later, Professor Alfieri presented several excellent examples of true rare patients, mostly with complicated congenital heart diseases, who were expertly manged in his Centre. There were two case-based presentations on rare diseases and on the optimal management strategy in the middle of the session. Each presentation was delivered by the managing physician from the Krakow Centre and commented by two national and international Experts.
The first case on the inherent difficulties and uncertainties on the management of pregnant patient with heart failure on the basis of end stage hypertrophic cardiomyopathy, which was additionally complicated with secondary pulmonary hypertension, was presented by Doctor Lidia Tomkiewicz-Pająk. The case was discussed by Professor Sabine Pankuweit from Marburg, Germany and Professor Deddo Moertl from St. Poelten, Austria. Professor Pankuweit, who is an expert in cardiovascular genetics, commented on the molecular mechanisms that may have caused the transition from the compensated hypertrophic cardiomyopathy to its burned-out phase. Professor Pankuweit stressed the potential role of molecular studies in the future, however, at the same time underlined that at present we are not ready yet… Professor Moertl, who is an expert in the management of pulmonary hypertension, stressed the importance of highly accurate hemodynamic measurements, that may have a decisive role in the prescription of adequate pharmaco-therapy.
The second case on the management of middle-age woman with unoperated tetralogy of Fallot (ToF) and concomitant aortic stenosis was delivered by Associate to Professor Andrzej Gackowski, and discussed by Professor Egle Erminiene from Kaunas, Lithuania and Doctor Jakub Podolec from Krakow Centre. Professor Erminiene, being a specialist in cardiac imaging, commented on the difficulties and also on the tips and tricks related to the establishment of the proper diagnosis in a patient with an uncorrected ToF, complicated with some other cardiac abnormalities. Doctor Jakub Podolec, an invasive cardiologist, discussed the best possible management strategy, including pros and cons of surgical intervention as well as potential percutaneus correction of aortic stenosis.
The final presentation of the symposium was given by Doctor Grzegorz Kopeć from the CRCD. Doctor Kopec focused on the important topic of registries of cardiovascular diseases. There is no doubt that registries, especially in the field of rare diseases, are invaluable source of epidemiology data and should be a cornerstone of any balanced financial decision., Moreover, Doctor Kopec pre- As in previous years, the lecture hall was nearly too small to accommodate the high turn-up of participants. Among many distinguished guests, we hosted Professor Garry Webb from the Cleveland Clinic, USA, Professor Piotr Hoffman from National Heart Institute, Warsaw, Poland, and many others. Unfortunately, due to time restrictions (scheduled time of 45 minutes), not everyone could actively participate in the vivid debate during the session. However, many participants stayed long outside the room to carry on with the ad hoc debate and discussions.
In summary, the highly interesting content of the session and case-based format of the lecture, has been once again a magnet for a high turn-up of participants from all over the world, many of whom took part in this meeting for a third time. This year, the great debate concentrated on the newly-proposed Classification of Rare Cardiovascular Diseases. As every voice count, right after the session the decision has been made to contact all session participants to ask them formally to share their view on the classification. At the moment, we are impatiently awaiting responses that have already started coming … 
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